Investor Tips New vaccine entrant gets approval before Novavax, while herd immunity ideas put sales in doubt. Articles You May Like The housing market is heading into 2025 with a worrying supply trend 10-year Treasury yield rises slightly, hovering near a seven-month high 3 Best Magnificent 7 Stocks to Buy for 2025 The boldest bitcoin predictions for 2025 are in — and most see prices doubling to $200,000 Jeju Air crash: Boeing shares fall after South Korea orders 737-800 inspection